3rd Quarter - Amendment
THORN RUN PARTNERS for NOVARTIS CORPORATION
Firm
Client
Income
$50,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 15, 2019 | $50,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Oct 30, 2019 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to Medicare and Medicaid reimbursement of biosimilars and drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON | — |
| ALEX DELPIZZO | — |
| GARY PALMQUIST | — |
| ANDREW ROSENBERG | — |
Health Issues HCR
Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148). Issues related to pharmaceutical pricing and biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON | — |
| ALEX DELPIZZO | — |
| GARY PALMQUIST | — |
| ANDREW ROSENBERG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.